![Generex Biotechnology Corp. Logo](/news-release/logo/216771/0/216771.jpg?lastModified=12%2F09%2F2016%2022%3A59%3A49&size=2)
Generex Biotechnology Creates Scientific Advisory Board to Further the Progression of Its Drug Development Programs
August 02, 2010 09:30 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., Aug. 2, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the...
![Generex Biotechnology Corp. Logo](/news-release/logo/216771/0/216771.jpg?lastModified=12%2F09%2F2016%2022%3A59%3A49&size=2)
Generex Announces AGM Results
July 30, 2010 16:30 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., July 30, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com) today announced the results of the Company's annual meeting of stockholders held...
![Generex Biotechnology Corp. Logo](/news-release/logo/216771/0/216771.jpg?lastModified=12%2F09%2F2016%2022%3A59%3A49&size=2)
Generex Provides Positive Update On Generex Oral-Lyn(TM) Pivotal Phase III Trial
July 28, 2010 09:30 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., July 28, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT), (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
![Generex Biotechnology Corp. Logo](/news-release/logo/216771/0/216771.jpg?lastModified=12%2F09%2F2016%2022%3A59%3A49&size=2)
Generex's Glucose RapidSpray(TM) Now Available at Boots UK Retail Chain Stores
July 15, 2010 09:30 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., July 15, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
![Generex Biotechnology Corp. Logo](/news-release/logo/216771/0/216771.jpg?lastModified=12%2F09%2F2016%2022%3A59%3A49&size=2)
Generex Announces Receipt of Favorable NASDAQ Listing Determination
July 15, 2010 07:34 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., July 15, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com) today announced its receipt of a decision by the NASDAQ Listing Qualifications...
![Generex Biotechnology Corp. Logo](/news-release/logo/216771/0/216771.jpg?lastModified=12%2F09%2F2016%2022%3A59%3A49&size=2)
Generex Oncology Granted United States Patent for AE37 Peptide Vaccine
July 13, 2010 09:30 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., July 13, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (Nasdaq:GNBT) today announced that its wholly-owned subsidiary, Antigen Express, Inc....
![Generex Biotechnology Corp. Logo](/news-release/logo/216771/0/216771.jpg?lastModified=12%2F09%2F2016%2022%3A59%3A49&size=2)
Generex Biotechnology Participates in Gateway to China Business Round Table Conference
July 07, 2010 12:18 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., July 7, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (Nasdaq:GNBT) today announced its participation in the Gateway to China Business Round Table...
![Generex Biotechnology Corp. Logo](/news-release/logo/216771/0/216771.jpg?lastModified=12%2F09%2F2016%2022%3A59%3A49&size=2)
Generex Biotechnology to Participate in World's Largest and Most Prestigious Diabetes Meeting
June 22, 2010 09:30 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., June 22, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (Nasdaq:GNBT) today announced its participation as an exhibitor during the 70th Scientific...
![Generex Biotechnology Corp. Logo](/news-release/logo/216771/0/216771.jpg?lastModified=12%2F09%2F2016%2022%3A59%3A49&size=2)
Generex Oncology Announces Presentations at the American Society of Clinical Oncology Annual Meeting and the 7th World Vaccine Conference
June 09, 2010 09:27 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., June 9, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com) today announced presentations on the technologies and products under development at...
![Generex Biotechnology Corp. Logo](/news-release/logo/216771/0/216771.jpg?lastModified=12%2F09%2F2016%2022%3A59%3A49&size=2)
Generex Biotechnology Reports Preliminary Outcomes and Trends From Ongoing Phase III Clinical Trial of Generex Oral-lyn(TM)
June 07, 2010 09:55 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., June 7, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the...